2012•BloodRequires access
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with “normal” FISH: correlations with clinicobiologic parameters
Gian Matteo Rigolin, Francesca Cibien, Sara Martinelli, Luca Formigaro, Lara Rizzotto, Elisa Tammiso, Elena Saccenti, Antonella Bardi, Francesco Cavazzini, Maria Ciccone, Ilaria Nichele, Giovanni Pizzolo, Francesco Zaja, Renato Fanin, Piero Galieni, Alessia Dalsass, Francesca Mestichelli, Nicoletta Testa, Massimo Negrini, Antonio Cuneo
Open publisher page 77 citations
Abstract
It is unclear whether karyotype aberrations that occur in regions uncovered by the standard fluorescence in situ hybridization (FISH) panel have prognostic relevance in chronic lymphocytic leukemia (CLL). We evaluated the significance of karyotypic aberrations in a learning cohort (LC; n = 64) and a validation cohort (VC; n = 84) of patients with chronic lymphocytic leukemia with "normal" FISH. An abnormal karyotype was found in 21.5% and 35.7% of cases in the LC and VC, respectively, and was associated with a lower immunophenotypic score (P = .030 in the LC, P = .035 in the VC), advanced stage (P = .040 in the VC), and need for treatment (P = .002 in the LC, P = < .0001 in the VC). The abnormal karyotype correlated with shorter time to first treatment and shorter survival in both the LC and the VC, representing the strongest prognostic parameter. In patients with chronic lymphocytic leukemia with normal FISH, karyotypic aberrations by conventional cytogenetics with novel mitogens identify a subset of cases with adverse prognostic features.